Groowe Groowe / Newsroom / JNJ
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

JNJ News

Johnson & Johnson

Wounded Warrior Project Announces New Board Leadership, Directors

prnewswire.com
BA NOC JNJ COO XRAY DHR

Fortune Unveils Speakers and Program Themes for 2026 Most Powerful Women Summit, Oct.12-14 in Santa Barbara

prnewswire.com
GOOGL GOOG C FLEX NDAQ NOW UPWK DD YUM SYF DB RBLX CRM JNJ BLKB

Major Depressive Disorder Clinical Trial Pipeline Boom as 75+ Companies are in the Race for Better Treatments | DelveInsight

globenewswire.com
AXSM VRTX RLMD VSTA PRAX NBIX ALTO LLY JNJ MRK ABBV BMY REGN BIIB ANVS ALEC LEXX COYA NVO IONQ NVDA AMD INTC GOOG MSFT AMZN TSLA AAPL META IBM CRM ADBE NFLX CMCSA VZ T KO PEP MCD DIS BA CAT GE XOM CVX JPM BAC WFC GS MS V MA HD WMT COST PG PFE MRNA GILD AMGN NVS TAK EXAS CRSP EDIT NTLA INCY ALKS ACAD AZN TEVA BHC LULU UBER LYFT SPCE PLTR SNOW DDOG CRWD ZS PANW FTNT NOW ADSK MCHP NXPI ON QCOM MU WDC SE MELI BABA JD PDD NTES BIDU IQ VIPS NIO XPEV LI RIVN LCID PLUG FCEL BE SPWR ENPH SEDG RUN NEO CLSK CRBU RXRX DTIL ADPT CYTK IMUX MNKD SRPT BNTX RVMD ACRS EXEL FGEN GNTX HRMY INSM ITRM KODK LPCN NCLH OCGN ORGO PACB PBYI PEGA PLRX PRGS PTON PYPL QGEN QRVO RDNT REPL ROKU RYAAY SAVA SBAC SCLX SDRL SEIC SIRI SMCI SNPS SOFI SPOT SSYS STX SWKS SYK TCOM TEAM TER TGT TMO TMUS TXN UAL ULTA UPS VRSK WDAY XEL XYL ZBRA

Zifo to Spotlight Scientific Process, AI-ready Data and the Future of R&D at Lab of the Future Europe 2026

prnewswire.com
JNJ

Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape

globenewswire.com
ABBV JNJ NVS UCB PFE GSK AMGN LLY

EcoVadis and Kearney Report: Unreliable Supplier Data May Cause Companies to Underestimate Supply Chain Emissions by Up to 3x

prnewswire.com
JNJ

Trialynx Wins Forge’s DPHARM Idol Disrupt 2026

globenewswire.com
NVS SNY PFE JNJ

Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight

prnewswire.com
VBIO AMGN JNJ BMY IMVT

Joint Replacement Devices Market Size to Hit $31.09 Billion by 2030 – MarketsandMarkets™

globenewswire.com
SYK JNJ ZBH GMED ENOV CNMD PAR

Viral Vector Collaboration and Licensing Deals 2016-2026 Report Examines 450+ Transactions, Deal Structures and Market Trends

globenewswire.com
AZN BIIB BMY LLY GILD JNJ NVS PFE SNY TMO VRTX